Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Amniocentesis in HIV pregnant women: 16 years of experience.

Simões M, Marques C, Gonçalves A, Pereira AP, Correia J, Castela J, Guerreiro C.

Infect Dis Obstet Gynecol. 2013;2013:914272. doi: 10.1155/2013/914272. Epub 2013 Jul 21.

2.

Recommendations for amniocentesis in HIV-positive women.

Constantatos SN, Boutall AH, Stewart CJ.

S Afr Med J. 2014 Dec;104(12):844-5.

PMID:
26042263
3.

HIV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women?

Maiques V, García-Tejedor A, Perales A, Córdoba J, Esteban RJ.

Eur J Obstet Gynecol Reprod Biol. 2003 Jun 10;108(2):137-41.

PMID:
12781400
4.

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.

Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R.

Ann Intern Med. 2015 Jan 20;162(2):90-9. doi: 10.7326/M13-2005.

5.

Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.

Kowalska A, Niemiec T, El Midaoui A, Burkacka E.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):459-68.

PMID:
15010556
6.

Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series.

Somigliana E, Bucceri AM, Tibaldi C, Alberico S, Ravizza M, Savasi V, Marini S, Matrone R, Pardi G; Italian Collaborative Study on HIV Infection in Pregnancy..

Am J Obstet Gynecol. 2005 Aug;193(2):437-42.

PMID:
16098867
7.

Amniocentesis in pregnant HIV-infected patients. Absence of mother-to-child viral transmission in a series of selected patients.

Ekoukou D, Khuong-Josses MA, Ghibaudo N, Mechali D, Rotten D.

Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):212-7. doi: 10.1016/j.ejogrb.2008.04.004. Epub 2008 Jun 27.

PMID:
18584937
8.

Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.

Liotta G, Mancinelli S, Nielsen-Saines K, Gennaro E, Scarcella P, Magid NA, Germano P, Jere H, Guidotti G, Buonomo E, Ciccacci F, Palombi L, Marazzi MC.

PLoS One. 2013 Aug 19;8(8):e71653. doi: 10.1371/journal.pone.0071653. eCollection 2013. Erratum in: PLoS One. 2013;8(8). doi: 10.1371/annotation/9ab4708e-650e-411a-b72f-bb85e0845469. Gennaro, E [corrected to Gennaro, Elisabetta]; Guidotti, Gianni [corrected to Guidotti, Giovanni].

9.

Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.

Joao EC, Gouvêa MI, Menezes JA, Sidi LC, Cruz ML, Berardo PT, Ceci L, Cardoso CA, Teixeira Mde L, Calvet GA, Matos HJ.

Int J STD AIDS. 2012 Jan;23(1):44-7. doi: 10.1258/ijsa.2011.010545.

PMID:
22362687
10.

The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

McCabe CJ, Goldie SJ, Fisman DN.

PLoS One. 2010 Apr 13;5(4):e10154. doi: 10.1371/journal.pone.0010154.

11.

The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.

Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, Sluman MA, van der Ende ME, Godfried MH.

BJOG. 2007 Feb;114(2):148-55.

12.

Antiretroviral treatment during pregnancy.

Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM; Swiss HIV Cohort Study (SHCS).; Swiss Mother & Child HIV Cohort Study (MoCHiV)..

AIDS. 2008 Nov 12;22(17):2323-30. doi: 10.1097/QAD.0b013e3283189bf1.

PMID:
18981771
13.
14.

Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.

French CE, Tookey PA, Cortina-Borja M, de Ruiter A, Townsend CL, Thorne C.

Antivir Ther. 2013;18(2):183-92. doi: 10.3851/IMP2327. Epub 2012 Aug 22.

PMID:
23475123
15.

[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].

Tempelman C, Timmermans S, Godfried MH, Dieleman JP, Boer K, van der Ende ME.

Ned Tijdschr Geneeskd. 2004 Oct 9;148(41):2021-5. Dutch.

PMID:
15553999
16.

Genotypic resistance tests for the management of the HIV-infected pregnant woman.

Bassetti D, Cargnel A.

Scand J Infect Dis Suppl. 2003;106:70-4. Review.

PMID:
15000589
17.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group..

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
18.

Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.

Joseph O, Biodun O, Michael E.

J Coll Physicians Surg Pak. 2011 Jun;21(6):356-9. doi: 07.2011/JCPSP.356359.

PMID:
21711992
19.

[Factors associated with virological response in women receiving highly-active antiretroviral prophylaxis for HIV-1 mother-to-child transmission].

Palacios R, Senise JF, Vaz MJ, Castelo A.

Enferm Infecc Microbiol Clin. 2008 Aug-Sep;26(7):411-5. Spanish.

PMID:
18842235
20.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370

Supplemental Content

Support Center